tag:blogger.com,1999:blog-35204126.post-1159633914848359392006-09-30T09:22:00.000-07:002006-10-16T15:32:51.730-07:00/* NOTE: This page is very much a "work in progress." Suggestions appreciated. */<br /><br /><strong>General References:</strong><br /><br />The Commission for Systemic Interoperability's publication "Ending the Document Game" has a 41 page appendix (Appendix C) summarizing all standards up to their 2005 report. This is among the most thoughtful, historical, and comprehensive summaries available.<br /><ul><li><a href="http://endingthedocumentgame.gov/PDFs/PastRecommendations.pdf#search=%22ncvhs%20november%20%22clinical%20data%20terminologies%22%22">Follow this link for Appendix C</a></li></ul><br />NCVHS (2/2/2004 note to Secretary Thompson) identified three types of standards:<br /><br /><strong>Message format standards</strong><br /><br /><a href="http://www.astm.org/cgi-bin/SoftCart.exe/DATABASE.CART/REDLINE_PAGES/E2369.htm?E+mystore">Continuity of Care Record (CCR)<br /></a><p>NCPDP Script telecommunications</p><p><em>NCPDP Script formulary and benefit information</em></p><blockquote>This standard displays the formulary status and alternative drugs as well as co-pays and other status information</blockquote><p><em>NCPDP Script medication history</em></p><blockquote>Includes the status, provider, patient, coordination of benefit, repeatable<br />drug, request, and response segments of SCRIPT</blockquote><p><em>NCPDP Script fill status</em></p><blockquote>Informs when Rx filled, not filled, or partially filled. Includes provider,<br />patient, and drug segments of SCRIPT message. Not yet generally used.</blockquote><p><em>NCPDP Script change request and response</em></p><blockquote>This the primary means by which a pharmacy may request of a provider a<br />clarification, correction, or change in drug as a result of therapeutic<br />substitution or other rationale.</blockquote><p><em>NDPDP Script cancellation</em></p><blockquote>Cancels a prescription previously sent to a pharmacy. Not generally used at<br />present.</blockquote><p><em>SIG messages</em></p><blockquote>Indication, dose, dose calculation, dose restriction, route, frequency,<br />interval, site, administration time and duration, stop</blockquote><p><em>X-12N-270/271 - eligibility</em></p><p></p><p><em>X12N-278 prior authorization</em></p><blockquote>This is the portion of X12-278 that supports prior authorization. It required<br />header information, requester, subscriber, utilization management, and other<br />relevant information. </blockquote><p><br /><strong>Terminology standards</strong> </p><p><em>RxNorm</em></p><blockquote>RxNorm is organized around normalized names for clinical drugs. These names<br />contain information on ingredients, strengths, and dose forms. It includes the<br />sematic clinical drug (ingredient plus strength and dose form) and the sematic<br />branded drug representation (proprietary, branded ingredient plus strength) </blockquote><ul><li><a href="http://www.nlm.nih.gov/research/umls/rxnorm/index.html">RxNorm site</a><br /></li></ul><p><strong>Identifier standards</strong><br /><strong></strong><br /><strong>Other Sites:</strong><br /></p><ul><li><a href="http://www.nehta.gov.au/">Australian National e-Health Transition Authority</a></li><li><a href="http://www.health.gov.au/internet/hconnect/publishing.nsf/Content/e-health-1lp">Australia eHealth site</a></li></ul><div class="blogger-post-footer"><img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/35204126-115963391484835939?l=www.markfrisse.com%2Ferx%2Fblog.html' alt='' /></div>Mark Frissenoreply@blogger.com0